Resource Centers
Medscape Journals
Specialty Spotlight
-
Lipids for Dummies -- Howard Weintraub, MD Offers Solid Advice for Lowering LDL-C
-
A Successful Campaign Against Antibiotic Overuse
-
Factors Applicants Value when Selecting an Emergency Medicine Residency
-
Exploring Genetic Susceptibility to Autism: An Expert Interview With Hakon Hakonarson, MD, PhD
-
Can the Nurse Practitioner Write a Prescription For Someone Who Is Not a Patient?
Medscape Community Resources
- 2009 H1N1 Influenza Vaccine in Pregnancy
- Lipids for Dummies -- Howard Weintraub, MD Offers Solid Advice for Lowering LDL-C
- A Successful Campaign Against Antibiotic Overuse
- Will There Ever Be a Big Brown Ribbon Outside the White House?
- Exploring Genetic Susceptibility to Autism: An Expert Interview With Hakon Hakonarson, MD, PhD
POLL
In a BMJ editorial published last month, mandatory screening of all electively admitted patients for MRSA in UK hospitals was criticized for being "unethical" and "unjustified," citing it as potentially harmful because of a potential delay in treatment. Do you favor or oppose mandatory screening for MRSA in hospitalized patients?
- A Treatment Option for Atrial Fibrillation
- A single medication with 4 indications
- A treatment option for ACS and DVT/PE
- ABILIFY® (aripiprazole)
- ACUVUE® Brand Contact Lenses
- ADHD treatment: Efficacy, insights, and dosing
- ALIMTA® (pemetrexed for injection)
- Argatroban
- Atrial Fibrillation Condition Site
- COSAMIN®DS
- CRESTOR® (rosuvastatin calcium)
- Carac® (fluorouracil cream 0.5%)
- Ciprodex® (ciprofloxacin 0.3% and dexamethasone 0.1%) Sterile Otic Suspension
- Clinical Management Center
- DanActive® and ACTIVIA® Information Center
- Diabetes in America
- ENABLEX® (darifenacin) Extended-Release Tablets 7.5 mg or 15 mg
- Epilepsy360: Connections in Care
- GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant]
- GEMZAR® (gemcitabine HCI)
- GEODON® (ziprasidone HCI)
- Genomic Advances in Cardiovascular Care
- Heartmate II® Left Ventricular Assist System
- IL-6 and Rheumatoid Arthritis
- ISENTRESS® (raltegravir) Tablets
- Kidney Transplantation
- LEVAQUIN® (levofloxacin) tablets/injection
- LOVAZA® (omega-3-acid ethyl esters)
- NEW INTUNIV™ (guanfacine) Extended Release Tablets
- NUCYNTA (tapentadol)
- NUVIGIL® (armodafinil) Tablets [C-IV]
- Navigenics® Genetic Risk Assessment Services
- Neuroendocrine tumors: Increasing in incidence and easy to overlook
- Neutrogena® Pure & Free™ Baby Sunblock Lotion
- OPTIMAL Forum™
- Onglyza™ (saxagliptin) InfoSite
- PEGASYS (peginterferon alfa-2a) for injection
- PREMARIN® (conjugated estrogens tablets, USP)
- PRISTIQ® (desvenlafaxine)
- ProAir® HFA
- Professional Liability Risk: Facts, Perspectives, and Management Strategies InfoSite
- QuickVue® Influenza A+B Test
- REBIF® (interferon beta-1a)
- RITUXAN® (Rituximab)
- Reclast® (zoledronic acid) injection
- Research VEGF: Emerging Research Around Targeting VEGF
- Risk of Osteoporosis
- Survivorship and Early Breast Cancer Information
- Symbyax® (Olanzapine and Fluoxetine HCl Capsules)
- TOVIAZ® (fesoterodine fumarate)
- Talecris Hypermunes
- Targeted Biologic Therapy in Breast Cancer
- Targeting CD20: Scientific Insights and Implications for Therapy
- The HER signaling network and cancer
- The Pain Institute
- The Science of Facial Aging
- Treatment of Pulmonary Arterial Hypertension
- VESIcare (solifenacin succinate) tablets
- VIGAMOX® solution
- Vyvanse (lisdexamfetamine dimesylate)
- XYZAL® (levocetirizine dihydrochloride)